Preliminary experiences closing secundum atrial septal defect using the modified Cardia Intrasept device.
During the past decade, transcatheter occlusion of secundum atrial septal defects (Type II ASDs) has become a widely accepted alternative to surgical closure. To date, over 6,000 patients have been treated with the Cardia Intrasept PFO occluder (Cardia Inc., Burnsville, Minnesota) for the percutaneous closure of patent foramen ovale (PFO). This is a report of the use of a modified Intrasept device to close Type II ASDs in 4 patients.
Chessa
Massimo
M
Pediatric Cardiology and Adults with Congenital Heart Disease, IRCCS--Policlinico San Donato, San Donato, Milan, Italy. massimo.chessa@grupposandonato.it
Butera
Gianfranco
G
Carminati
Mario
M
D000293:Adolescent; D006328:Cardiac Catheterization; D002648:Child; D004452:Echocardiography; D018618:Echocardiography, Doppler, Color; D005500:Follow-Up Studies; D006344:Heart Septal Defects, Atrial / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D019736:Prostheses and Implants; D016896:Treatment Outcome